GENinCode Plc (LON:GENI – Get Free Report) shares reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as GBX 2.50 ($0.03) and last traded at GBX 2.50 ($0.03), with a volume of 3269155 shares traded. The stock had previously closed at GBX 2.55 ($0.03).
GENinCode Stock Performance
The firm has a 50 day moving average price of GBX 3.64 and a 200 day moving average price of GBX 4.15. The stock has a market cap of £4.44 million, a PE ratio of -0.73 and a beta of 0.66. The company has a quick ratio of 15.89, a current ratio of 2.60 and a debt-to-equity ratio of 9.28.
GENinCode Company Profile
GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.
GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.
Featured Stories
- Five stocks we like better than GENinCode
- Top Biotech Stocks: Exploring Innovation Opportunities
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- What is a support level?
- The 3 Most Talked About Investments on WallStreetBets Right Now
- What Are the FAANG Stocks and Are They Good Investments?
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
